New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to Treat Patients
Every Cure to Receive $48.3M from ARPA-H to Develop AI-Driven Platform to Revolutionize Future of Drug Development and Repurposing
ARPA-H contract will supercharge Every Cure’s work to identify existing medicines that can be repurposed to treat currently untreated diseases. Initial progress utilizing a pilot version of the AI platform and stakeholder engagement has led to the identification of potential treatments for sickle cell disease, ALS, and autism spectrum disorder.
Every Cure Wins Cure. Xchange Challenge: Health AI for Good
Winning startups join more than 20 companies at New York City’s cutting-edge healthcare innovation campus
Every Cure Co-Founder Dr. David Fajgenbaum Honored as Philadelphia Citizen of the Year to Commemorate 10 Years in Remission After Discovering a Cure for His Deadly Disease
David Fajgenbaum discovered a repurposed drug to save his own life and is now on a mission with Every Cure Co-Founders Grant Mitchell and Tracey Sikora to repurpose drugs for millions more.
Every Cure to Leverage Atropos Health’s GENEVA OS and Evidence Network to Advance the Discovery and Development of Therapies for Underserved Populations
New Partnership Enables Real World Data Confirmation of Drug Repurposing Opportunities and Trial Emulation Capabilities to Speed Clinical Development
Every Cure Co-Founder Receives the Inaugural Elevate Prize Founder’s Award for their Bold Mission of Saving Lives with Existing Drugs
David Fajgenbaum discovered a repurposed drug to save his own life and is now on a mission with Every Cure Co-Founders Grant Mitchell and Tracey Sikora to repurpose drugs for millions more.
Every Cure Announces Foundational Funding Partners and Major Milestones
Partnerships with the Chan Zuckerberg Initiative, Flagship Pioneering, Lyda Hill Philanthropies, and Elevate Prize Foundation Will Accelerate the Discovery of Cures Hidden on Pharmacy Shelves
Every Cure Announces Leaders Across Healthcare Joining its Board of Directors
Board of Directors will lead the nonprofit organization on its mission of unlocking hidden cures.
Angiosarcoma Patient Celebrates 7-Year Remission with Pioneering Use of PD-1 Inhibitor: Every Cure Unleashes AI to Ensure No Treatment is Left Overlooked
An Angiosarcoma patient facing a grave prognosis found a lifeline in a repurposed PD-1 inhibitor, a treatment hidden in the medical literature for three years. Every Cure and its partners are building on this breakthrough, deploying innovative AI algorithms that evaluate the potential of every drug for every disease. The efforts have already begun to […]
Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease Patients
Worldwide Clinical Trials (Worldwide), the industry’s leading global, full-service contract research organization (CRO), has partnered with Every Cure, a nonprofit organization that unlocks new, often undiscovered uses for existing approved drugs by leveraging data, artificial intelligence (AI), and efficient clinical trials.
First Life Saved with AI-Discovered Repurposed Medicine for Castleman Disease with Significant Potential Applications to Treat Other Illnesses
A 50-year-old patient battling life-threatening Castleman disease was provided adalimumab as a treatment of last resort following its identification by AI-guided discovery. Every Cure and its partners are expanding upon this discovery to harness a novel AI algorithm that calculates the potential use of every drug to treat every disease. Initial promising candidates for further […]
Medable Partners with Every Cure to Accelerate Discovery of Treatments for Rare Diseases
Medable Inc., the industry-leading technology platform for patient-centered clinical trials, today announced a partnership with non-profit Every Cure, which officially launched in September in partnership with the Clinton Global Initiative to scale up an innovative “drug repurposing” research approach to identify treatments for rare diseases.